To determine the 6 month PFS, safety and tolerability of durvalumab in combination with cisplatin and pemetrexed in MPM planned for 1st line chemo Planned sample size 54 at approx. 14 sites Protocol finalised and granted central ethics approval First sites opened December 2016 There is an initial safety run-in of 6 patients to review … Continue reading ALTG 15/003 DREAM: A phase II trial of durvalumab with first line chemotherapy in mesothelioma with a safety run in – A Nowak